Does the Cercle AI tool make decisions about my treatment?

The prediction tool does not make clinical decisions. Your specialist reviews the AI-generated predictions alongside everything else they know about your situation, and the treatment plan is always determined by them in consultation with you. AI provides an additional layer of evidence. The decision-making remains with your care team.

What does "patient insights" mean in practice?

It means the prediction is generated based on data from patients with characteristics similar to yours, rather than from the general population. Factors such as age, ovarian reserve, treatment history, and clinical profile are all taken into account. The result is a probability estimate that is more relevant to your specific situation than a generic success rate figure.

Australia’s First AI-Powered Patient Insight Tool

Status

Overview Cercle AI Stim Assist Embryo Grading FAQs

Fertility treatment involves many decisions, big and small. At Genea, we are using artificial intelligence and a purpose-built data platform to make those decisions sharper and more personalised than ever before.

Genea specialists have always tailored treatment to the individual by drawing on clinical experience, patient history, and the latest research. What's changed is the depth of data behind those decisions. With over 40 years of Genea-specific outcomes now accessible in real time, every recommendation is backed by more personalised evidence than ever previously possible.

Australia's first AI-powered patient insight tool

In partnership with Cercle AI, Genea is the first fertility provider in Australia to introduce an AI-powered patient insight tool built on our real-world data.

Cercle AI analysed over one billion global data points, together with Genea data, to deliver a tool that generates personalised insights across multiple cycles, including egg retrieval expectations and treatment pathway considerations, to help patients make more informed decisions with their specialist. Rather than relying on general population averages, your specialist can more easily access data that relates specifically to someone with your profile, history, and circumstances.

This tool doesn't make decisions. It helps inform them. Your specialist reviews the patient insights alongside everything else they know about you, and together you decide on the path forward.

What this means for you:

Insights built around your profile - based on data from patients with similar characteristics to you
Faster answers - AI surfaces evidence in real time, so decisions can be made with less delay
Consistent, standardised care - insights from across the entire Genea network mean every patient benefits from collective outcomes, regardless of which clinic they attend
Human expertise, enhanced by data - your specialist still makes every decision together with you, but with more evidence behind them than ever before

One view across our entire network

Genea has always collected clinical and laboratory data across our network. What has changed is how we can access and act on it.

We have built a centralised data platform that brings together clinical and laboratory information from across all Genea clinics into a single, connected system. For the first time, our clinic and lab managers can view their own performance data in real time and see how their outcomes compare across the network, identifying patterns and applying insights from one location to benefit patients everywhere.

This is not new data. It is existing data made accessible, comparable, and actionable in a way it has never been before. For example, when a clinic in Canberra achieves an exceptional blastocyst rate using a particular protocol, that insight becomes visible to the whole network. This kind of connected intelligence helps us identify what works, raise the standard of care, and apply insights from one clinic to benefit patients everywhere.

Incorporating Cercle AI across your treatment journey

The patient insight tool is just one part of what the Cercle AI platform makes possible at Genea. We are building on that foundation to support other critical points in your treatment journey.

Raising the standard of embryo grading

Every embryo developed in our Geri® incubator is continuously monitored through time-lapse imaging. Those images are now processed through the Cercle AI platform to support quality control and help standardise embryo grading across our team of embryologists.

Embryo grading is a skilled, expert process, but like any human assessment, it can be subject to variability between individuals. AI-assisted grading works alongside our embryologists assessment, providing a consistent reference point that ensures every embryo is evaluated to the same standard, regardless of which embryologist is assessing it or which clinic they are based at.

Technology that serves people, not the other way around

None of this technology replaces the relationship between you and your care team. Our specialists use these tools to spend less time searching for answers and more time with you to understand your individual situation and build a treatment plan that gives you the best possible chance.

Your specialist is still making the decisions. They are still bringing their clinical expertise and knowledge of you as an individual to every recommendation they make. What Cercle AI adds is a deeper, faster, more complete view of the evidence behind those decisions.

Find out more about Genea’s technology

Learn about the Geri® time-lapse incubator
Discover Grow™, a world-first app that lets patients watch their embryos develop

Cercle AI-Powered Patient Insight Tool